Back

Does a higher body mass index influence additional presence of low voltage areas in the left atrium in patients with persistent atrial fibrillation?

7 April 2024 (08:30 - 15:00)
Organised by: Logo
Congress Presentation Part of: Poster session on atrial fibrillation and supraventricular tachycardia Rhythm Control, Catheter Ablation EHRA Premium Access EHRA 2024 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Mr Pellumb Haxhikadrija

University hospital Jena, Jena (Germany)

116 More presentations in this session

Presentation thumbnail
Left atrial strain measurement in patients with heart failure and atrial fibrillation compared to a control group
Doctor L. Herzer (Jena, DE)
Abstract Slides Video
Presentation thumbnail
Atrial fibrillation after transcatheter tricuspid valve repair: rhythm control strategies and outcomes
Doctor J. Schipper (Cologne, DE)
Abstract
Presentation thumbnail
Left atrial strain defines functional and structural remodeling in patients with persistent atrial fibrillation
Doctor A. Grosse (Jena, DE)
Abstract Slides Video
Presentation thumbnail
Cryoballoon ablation for atrial fibrillation in young adults: a propensity-score matching comparison with an older cohort
Presentation thumbnail
Procedural safety and outcome of additional left atrial posterior wall ablation using pulse field ablation for atrial fibrillation
Doctor J. Tay Cheong Kiat (Singapore, SG)
Abstract Slides Video

Access the full session

Session thumbnail
Poster session on atrial fibrillation and supraventricular tachycardia

The Event

Event poster

EHRA 2024

7 April - 9 April 2024
You may be interested in
thumbnail
Congress Presentation
J-curved phenomenon between the prevalence of left atrial low-voltage areas and body mass index existed in patients with atrial fibrillation ablation
thumbnail
Congress Presentation
The impact of obesity on the left atrium and arrhythmia recurrence in patients with atrial fibrillation undergoing ablation.
thumbnail
Congress Presentation
Spatial relationship between left peri-atrial fat with underlying arrhythmogenic substrate in patients with atrial fibrillation - innocent bystander or culprit?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources